rxstat › Shortages › Esomeprazole

Esomeprazole shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Esomeprazole products are in shortage in Canada (12 of 26 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Oct 10, 2027.
Products affected
12 of 26
In shortage since
Apr 23, 2025
Est. full return
Oct 10, 2027
Reports on file
122
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-ESOMEPRAZOLE
20MG · TABLET (DELAYED-RELEASE) · APOTEX INC
DIN 02339099 · since May 12, 2026, est. end Jul 17, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-ESOMEPRAZOLE
40MG · TABLET (DELAYED-RELEASE) · APOTEX INC
DIN 02339102 · since May 19, 2026, est. end Jul 17, 2026 · Disruption of the manufacture of the drug.
Active shortage
SANDOZ ESOMEPRAZOLE
20MG · TABLET (DELAYED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02460920 · since Jun 15, 2026, est. end Jul 24, 2026 · Delay in shipping of the drug.
Active shortage
ESOMEPRAZOLE
20MG · TABLET (DELAYED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02520699 · since Mar 12, 2026, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
PMSC-ESOMEPRAZOLE DR
20MG · TABLET (DELAYED-RELEASE) · PHARMASCIENCE INC
DIN 02528479 · since Nov 12, 2025, est. end Oct 10, 2027 · Disruption of the manufacture of the drug.
Active shortage
PMSC-ESOMEPRAZOLE DR
40MG · TABLET (DELAYED-RELEASE) · PHARMASCIENCE INC
DIN 02528487 · since Oct 29, 2025, est. end Oct 10, 2027 · Disruption of the manufacture of the drug.
Active shortage
MYL-ESOMEPRAZOLE
40MG · TABLET (DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02479427 · since Oct 17, 2025, est. end Oct 27, 2026 · Disruption of the manufacture of the drug.
Active shortage
TARO-ESOMEPRAZOLE
40MG · TABLET (DELAYED-RELEASE) · SUN PHARMA CANADA INC
DIN 02423987 · since Oct 1, 2025, est. end Jun 26, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-ESOMEPRAZOLE
40MG · TABLET (DELAYED-RELEASE) · APOTEX INC
DIN 02339102 · since Jan 6, 2026, est. end Apr 24, 2026 · Disruption of the manufacture of the drug.
Active shortage
ESOMEPRAZOLE
40MG · TABLET (DELAYED-RELEASE) · SANIS HEALTH INC
DIN 02431173 · since Aug 11, 2025, est. end Oct 9, 2026 · Disruption of the manufacture of the drug.
Active shortage
ESOMEPRAZOLE
20MG · TABLET (DELAYED-RELEASE) · SANIS HEALTH INC
DIN 02535335 · since Aug 11, 2025, est. end Oct 9, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-ESOMEPRAZOLE
40MG · TABLET (DELAYED-RELEASE) · TEVA CANADA LIMITED
DIN 02423863 · since Aug 19, 2025, no end estimate · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Esomeprazole is currently affected by 12 active shortage reports filed with Health Canada by APOTEX INC, SANDOZ CANADA INCORPORATED, JAMP PHARMA CORPORATION, PHARMASCIENCE INC and 4 others.

The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Esomeprazole is classified under “DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)” (ATC A02BC).

Recent changes

Common questions

When will Esomeprazole be back in stock in Canada?

The latest manufacturer estimate is Oct 10, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Esomeprazole in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (drugs for peptic ulcer and gastroesophageal reflux disease (gerd))

Widespread shortageFamotidine3 of 13 reported products affected · est. return Sep 18, 2026Partial shortageCimetidine3 of 9 reported products affectedPartial shortageLansoprazole6 of 22 reported products affected · est. return Dec 29, 2026Partial shortageOmeprazole10 of 22 reported products affected · est. return Aug 14, 2026Partial shortagePantoprazole7 of 35 reported products affected · est. return Sep 29, 2026Partial shortageRabeprazole4 of 21 reported products affected · est. return Jun 30, 2026

All drugs for peptic ulcer and gastroesophageal reflux disease (gerd) shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.